ECOR electroCore (ECOR) Insider Trading, Ownership & Congress Trades
Medical Devices · Electromedical & electrotherapeutic apparatus · CIK 0001560258
C-suite buying · 1
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
14
13F, latest reported quarter
Conversions, 180 days
3
Codes C/M, not in net · $90.0K priced
What the filings say about ECOR
Insiders, 180 days
-$72.4K net sold
2 buyers · 1 seller · 0% of sales under a 10b5-1 plan
electroCore insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, electroCore, Inc. insiders sold a net $72.4K of stock across 61 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-29.
Insider
Filed
Shares
Value
Since filing
Context
- 11 earlier Form 4 trades (code P or S) here by this insider (11 buys), the last on Aug 13, 2026.
- +54.0% median (+45.0% mean) 90-day return after 10 previous buys.
- The trade is 1.4% of the 363,904 shares held after it.
- 1 other insider bought within 30 days.
- 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Errico Thomas J. bought about $49.1K of ECOR on Sep 14, 2026; 1 other insider bought within 30 days and 14 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 3.8% of the 130,000 shares held after it.
- 1 other insider bought within 30 days.
- 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Fox Michael bought about $49.0K of ECOR on Sep 11, 2026; 1 other insider bought within 30 days and 14 funds added in the latest 13F quarter.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Aug 24, 2026.
- The trade is 3.5% of the 84,889 shares held after it.
- No other insider sold within 30 days.
- 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO and Interim President Lev Joshua S. sold about $28.1K of ECOR on Aug 25, 2026; 14 funds added in the latest 13F quarter.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Aug 21, 2026.
- The trade is 5.9% of the 84,889 shares held after it.
- No other insider sold within 30 days.
- 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO and Interim President Lev Joshua S. sold about $49.4K of ECOR on Aug 24, 2026; 14 funds added in the latest 13F quarter.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on May 28, 2026.
- The trade is 14.1% of the 84,889 shares held after it.
- No other insider sold within 30 days.
- 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CFO and Interim President Lev Joshua S. sold about $122.6K of ECOR on Aug 21, 2026; 14 funds added in the latest 13F quarter.61 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$72.4K over 180 days
-$52.8K over 90 days
more than 57% of Medical Devices
Congress
no House purchase disclosed in the last 12 months
Funds
14 funds bought in last quarter
below 78% of Medical Devices
Revenue
+27.2% year over year
more than 78% of Medical Devices
Margin
-43.6% net margin
below 66% of Medical Devices
Buybacks
no share repurchases reported
Short interest
5.8% of the float short (float per yahoo 2026-10-27) · 4.4 days to cover · settled 2026-10-15
more than 54% of Medical Devices
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch ECOR
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+55.8%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns ECOR: institutional holders (13F)
13F holdings, latest reported quarter
211,639 sh
$1.8M
94,000 sh
$812.2K
92,060 sh
$795.4K
73,149 sh
$632.2K
66,506 sh
$574.6K
Congress trades in ECOR
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
ECOR planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
ECOR mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Ultra-Small Company Fund
$216.0K position · as of 2026-06-30
0.2%
iShares Micro-Cap ETF
$151.7K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$10.4K position · as of 2026-06-30
0.0%
Fidelity Extended Market Index Fund
$322.8K position · as of 2026-05-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$533.1K position · as of 2026-06-30
0.0%
Fidelity Nasdaq Composite Index Fund
$105.8K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Daniel Goldberger
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$1.6M
$226.2K
$707.5K
+16%
n/a
2024
$1.6M
$2.7M
$600.7K
+320%
n/a
2023
$1.3M
$1.3M
$679.3K
+54%
n/a
2022
$997.6K
$796.7K
$614.8K
-56%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $72.4K sold by insiders over 180 days, 14 funds added last quarter. Each figure is a federal filing, dated the day it went public.
ECOR financials
Revenue growth
+27.2%
XBRL, annual
Net margin
-43.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$37.0M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM ECOR
| FY Dec 2025 | $32.0M |
| FY Dec 2024 | $25.2M |
| FY Dec 2023 | $16.0M |
| FY Dec 2022 | $8.6M |
| FY Dec 2021 | $5.5M |
| Jun 2026 | $9.4M |
| Mar 2026 | $9.6M |
| Dec 2025 | $9.2M |
| Sep 2025 | $8.7M |
| Jun 2025 | $7.4M |
| Mar 2025 | $6.7M |
| Dec 2024 | $7.0M |
| Sep 2024 | $6.6M |
At each fiscal year end
Single quarter
Net margin, TTM
-40.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM ECOR
| FY Dec 2025 | -43.6% |
| FY Dec 2024 | -47.2% |
| FY Dec 2023 | -117.5% |
| FY Dec 2022 | -257.9% |
| FY Dec 2021 | -315.8% |
| Jun 2026 | -32.4% |
| Mar 2026 | -55.0% |
| Dec 2025 | -32.8% |
| Sep 2025 | -39.2% |
| Jun 2025 | -49.7% |
| Mar 2025 | -57.4% |
| Dec 2024 | -45.8% |
| Sep 2024 | -38.1% |
At each fiscal year end
Single quarter
Free cash flow, TTM
-$9.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM ECOR
| FY Dec 2025 | -$8.3M |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | -$16.7M |
| FY Dec 2021 | -$13.7M |
| Jun 2026 | -$3.5M |
| Mar 2026 | -$3.0M |
| Dec 2025 | -$1.5M |
| Sep 2025 | -$1.7M |
| Jun 2025 | -$648.0K |
| Mar 2025 | -$4.4M |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity ECOR
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.19x |
| FY Dec 2023 | 0.19x |
| FY Dec 2022 | 0.08x |
| FY Dec 2021 | 0.04x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | 1.27x |
| Mar 2025 | 0.32x |
| Dec 2024 | 0.19x |
| Sep 2024 | 0.15x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-1.44x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt ECOR
| FY Dec 2025 | -1.18x |
| FY Dec 2024 | -4.93x |
| FY Dec 2023 | -10.41x |
| FY Dec 2022 | -11.81x |
| FY Dec 2021 | -9.67x |
| Jun 2026 | -1.44x |
| Mar 2026 | -1.02x |
| Dec 2025 | -1.18x |
| Sep 2025 | -1.16x |
| Jun 2025 | -5.39x |
| Mar 2025 | -6.20x |
| Dec 2024 | -4.93x |
| Sep 2024 | -6.25x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity ECOR
| FY Dec 2025 | -478.7% |
| FY Dec 2024 | -158.6% |
| FY Dec 2023 | -153.6% |
| FY Dec 2022 | -82.5% |
| FY Dec 2021 | -57.7% |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | -478.7% |
| Sep 2025 | -337.8% |
| Jun 2025 | -210.6% |
| Mar 2025 | -276.2% |
| Dec 2024 | -158.6% |
| Sep 2024 | -123.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-93.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets ECOR
| FY Dec 2025 | -71.4% |
| FY Dec 2024 | -65.0% |
| FY Dec 2023 | -92.2% |
| FY Dec 2022 | -65.6% |
| FY Dec 2021 | -46.3% |
| Jun 2026 | -93.4% |
| Mar 2026 | -97.6% |
| Dec 2025 | -71.4% |
| Sep 2025 | -66.7% |
| Jun 2025 | -71.8% |
| Mar 2025 | -81.8% |
| Dec 2024 | -65.0% |
| Sep 2024 | -61.7% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital ECOR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-269.3%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed ECOR
| FY Dec 2025 | -141.1% |
| FY Dec 2024 | -126.0% |
| FY Dec 2023 | -150.0% |
| FY Dec 2022 | -83.1% |
| FY Dec 2021 | -63.7% |
| Jun 2026 | -269.3% |
| Mar 2026 | -258.0% |
| Dec 2025 | -141.1% |
| Sep 2025 | -118.6% |
| Jun 2025 | -130.2% |
| Mar 2025 | -170.3% |
| Dec 2024 | -126.0% |
| Sep 2024 | -105.5% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing ECOR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$68.2M
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value ECOR
| FY Dec 2025 | $35.7M |
| FY Dec 2024 | $104.0M |
| FY Dec 2023 | $26.8M |
| FY Dec 2022 | $258.1M |
| FY Dec 2021 | $585.0M |
| Jun 2026 | $69.9M |
| Mar 2026 | $50.6M |
| Dec 2025 | $35.7M |
| Sep 2025 | $36.5M |
| Jun 2025 | $37.2M |
| Mar 2025 | $45.8M |
| Dec 2024 | $104.0M |
| Sep 2024 | $43.0M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-13.9%
TTM free cash flow over market value at close 2026-10-27
FCF yield ECOR
| FY Dec 2025 | -23.0% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | -6.1% |
| FY Dec 2021 | -2.2% |
| Jun 2026 | -13.6% |
| Mar 2026 | -14.1% |
| Dec 2025 | -23.0% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing ECOR
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $32.0M | $25.2M | $16.0M | $8.6M |
| Gross profit | $27.8M | $21.4M | $13.2M | $7.0M |
| Operating income | -$13.2M | -$12.2M | -$19.3M | -$22.9M |
| Net income | -$14.0M | -$11.9M | -$18.8M | -$22.2M |
| EPS (diluted) | -1.65 | -1.59 | -3.42 | -4.69 |
| Operating cash flow | -$8.2M | -$6.9M | -$14.7M | -$16.6M |
| Cash | $7.0M | $3.7M | $10.3M | $17.7M |
| Long-term debt | $6.6M | n/a | n/a | n/a |
SEC XBRL, fiscal years, as known on 2026-10-29
ECOR Stock Sonar score 6/7 axes
Find similar shapesCompareECOR ranks highest on growth (78th percentile) and insider conviction (64th), and lowest on profitability (12th), among Medical Devices peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
ECOR filings, in plain words
Are electroCore insiders buying or selling ECOR?
In the 180 days to 2026-10-29, electroCore insiders were net sellers, a net $72.4K: $207.2K of purchases and $279.6K of sales reported on Form 4, by 2 buyers and 1 seller.
Read the full summary
In the 180 days to 2026-10-29, electroCore insiders were net sellers of ECOR, a net $72.4K across purchases and sales reported on Form 4 by 2 buyers and 1 seller. 2 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. None of the 5 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-29, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
